CVAC, NGM

CureVac N.V. (CVAC)

Price (as of October 31)

7.28USD

Correlations

The correlation describes the statistical relationship between the value of two assets over time. Use this relationship to bet against an asset without shorting it or diversify your portfolio more effectively. Learn how you can use correlations to your advantage.

Lowest within Industry

Symbol Correlation

ANTX

AN2 Therapeutics, Inc.

-0.2

AXLA

Axcella Health Inc.

-0.16

CDXC

ChromaDex Corporation

-0.13

ASMB

Assembly Biosciences, Inc.

-0.12

BWV

Blue Water Vaccines, Inc.

-0.11

AMLX

Amylyx Pharmaceuticals, Inc.

-0.11

ARVN

Arvinas, Inc.

-0.11

APRE

Aprea Therapeutics, Inc.

-0.1

BNTX

BioNTech SE

-0.1

MRNA

Moderna, Inc.

-0.09

Show more

Highest within Industry

Symbol Correlation

ATOS

Atossa Therapeutics, Inc.

0.12

ADGI

Adagio Therapeutics, Inc.

0.1

CGTX

Cognition Therapeutics, Inc.

0.09

ANEB

Anebulo Pharmaceuticals, Inc.

0.08

ALGS

Aligos Therapeutics, Inc.

0.08

BCDA

BioCardia, Inc.

0.06

ADTX

Aditxt, Inc.

0.06

VRTX

Vertex Pharmaceuticals Incorporated

0.06

ACER

Acer Therapeutics Inc.

0.05

ALLO

Allogene Therapeutics, Inc.

0.05

Show more

Profile

Sector:
Healthcare
Industry:
Biotechnology

CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 clinical trial against influenza, as well as vaccine for lassa fever, yellow fever, respiratiory syncytial virus, rotavirus, malaria, and universal influenza. The company also develops RNA-based cancer immunotherapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck. The company was founded in 2000 and is headquartered in Tübingen, Germany.